The fetal hydantoin syndrome.
D000014:Abnormalities, Drug-Induced / Q000175:diagnosis; D000015:Abnormalities, Multiple / Q000139:chemically induced; D000293:Adolescent; D002675:Child, Preschool; D002658:Developmental Disabilities / Q000139:chemically induced; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D005333:Fetus / Q000502:physiology; D005385:Fingers / Q000002:abnormalities; D006130:Growth Disorders / Q000139:chemically induced; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects* / Q000627:therapeutic use; D006972:Hypertelorism / Q000139:chemically induced; D007223:Infant; D008607:Intellectual Disability / Q000139:chemically induced; D008297:Male; D008618:Mephobarbital / Q000627:therapeutic use; D009048:Motor Skills / Q000187:drug effects; D009056:Mouth Abnormalities / Q000139:chemically induced; D009207:Myoclonus / Q000188:drug therapy; D009264:Nails, Malformed; D010634:Phenobarbital / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011324:Primidone / Q000627:therapeutic use; D013388:Succinimides / Q000627:therapeutic use; D013577:Syndrome; D013723:Teratogens; D014034:Toes / Q000002:abnormalities
D006827:Hydantoins; D013388:Succinimides; D013723:Teratogens; D011324:Primidone; D008618:Mephobarbital; D010634:Phenobarbital